Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹117 Cr
Revenue (TTM)
₹111 Cr
Net Profit (TTM)
₹5 Cr
ROE
5 %
ROCE
8 %
P/E Ratio
25.4
P/B Ratio
1.6
Industry P/E
44.74
EV/EBITDA
8.8
Div. Yield
1.5 %
Debt to Equity
0.2
Book Value
₹63.1
EPS
₹4.3
Face value
10
Shares outstanding
11,446,290
CFO
₹113.26 Cr
EBITDA
₹136.50 Cr
Net Profit
₹53.18 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Smruthi Organics
| -12.8 | -9.0 | -12.5 | -11.9 | -7.4 | -13.6 | 11.8 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Smruthi Organics
| -4.8 | -30.3 | -0.8 | -36.0 | 63.6 | 276.0 | 3.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Smruthi Organics
|
102.0 | 116.7 | 111.0 | 4.6 | 7.0 | 7 | 25.4 | 1.6 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1989
Chairman
Purushotham Eaga
Managing Director
Purushotham Eaga
Headquarters
Solapur, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Smruthi Organics Ltd is ₹101.95 (BSE) as of 02-Apr-2026 IST. Smruthi Organics Ltd has given a return of -7.42% in the last 3 years.
The P/E ratio of Smruthi Organics Ltd is 25.43 times as on 02-Apr-2026, a 43 discount to its peers’ median range of 44.74 times.
The P/B ratio of Smruthi Organics Ltd is 1.62 times as on 02-Apr-2026, a 48 discount to its peers’ median range of 3.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
35.42
|
1.76
|
|
2024
|
46.58
|
2.40
|
|
2023
|
35.61
|
2.16
|
|
2022
|
24.69
|
3.82
|
|
2021
|
14.87
|
4.21
|
The 52-week high and low of Smruthi Organics Ltd are Rs 164.00 and Rs 95.00 as of 03-Apr-2026.
Smruthi Organics Ltd has a market capitalisation of ₹ 117 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Smruthi Organics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.04
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.